U.S. pharmaceutical stocks declined, with BioNTech (BNTX.US) dropping 11%, marking its largest intraday loss since March 10, after the company announced the termination of its Phase II colorectal cancer clinical trial. Moderna (MRNA.US) fell 5%, and Merck (MRK.US) dropped 1.3%.

Spot gold has just surpassed the $4,610.00/oz mark, now trading at $4,610.11/oz, up 0.19% on the day; the main COMEX gold futures contract is now at $4,662.10/oz, down 0.04% on the day.

Waller is under pressure to respond to a core issue: Is current inflation truly a problem? If so, how should it be addressed? On Thursday, some of Waller’s colleagues expressed their ongoing concerns over the inflation situation in the United States. Data released by the U.S. government on Wednesday showed that the annual inflation rate in July remained unchanged, staying significantly above the Federal Reserve’s 2% target for the 65th consecutive month. The Fed’s preferred measure to gauge und

US Stocks Movement | Marvell Technology (MRVL.US) plunges nearly 9% as Google’s large order is booked too slowly

The Dow Jones opened up 0.08%, the Nasdaq fell 0.1%, and the S&P 500 rose 0.05%. Among major tech stocks, Amazon rose 0.8%, Intel fell 1.98%, and Super Micro Computer declined 0.87%. The Nasdaq Golden Dragon China Index rose 0.34%, XPeng increased 2.29%, and iQIYI gained 1.73%.